Elevance Health director granted 563 deferred shares

Dixon Robert L JR reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Dixon Robert L JR reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health, Inc. director Robert L. Dixon Jr. received a grant of 563 shares of common stock in the form of deferred stock units under the company’s Board of Directors Compensation Program. Following this award, he directly holds 10,885 shares of Elevance Health common stock.

The deferred stock units will be settled in common stock upon the earlier of five years from the grant date or when Dixon ceases to serve on the board, unless he has elected a later payout date under the company’s Board of Directors Deferred Compensation Plan. This is a compensation-related award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 563 shares

Grant/Award 1 txn

Insider Dixon Robert L JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,885 shares (Direct)

Footnotes (2)

1. F1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. F2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock unit grant: 563 shares Post-transaction holdings: 10,885 shares Grant price: $0.0000 per share +1 more

4 metrics

Deferred stock unit grant 563 shares Grant of common stock units on 2026-05-13

Post-transaction holdings 10,885 shares Total common stock held directly after grant

Grant price $0.0000 per share Compensation-related award, not an open-market purchase

Vesting/payment trigger 5 years or board departure Deferred stock units payable in common stock at earliest event

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan, Form 4

4 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elevance Health (ELV) director Robert L. Dixon Jr. report on this Form 4?

Robert L. Dixon Jr. reported receiving 563 shares of Elevance Health common stock as deferred stock units. These were granted under the company’s Board of Directors Compensation Program as part of his director compensation, rather than purchased on the open market.

How many Elevance Health (ELV) shares does Robert L. Dixon Jr. hold after this grant?

After the grant, Robert L. Dixon Jr. holds 10,885 shares of Elevance Health common stock directly. This total includes the newly awarded 563 deferred stock units that will eventually be settled in company common stock under the plan’s terms.

Are the 563 Elevance Health (ELV) deferred stock units immediately payable in shares?

No, the 563 deferred stock units are not immediately payable. They will be settled in Elevance Health common stock after five years from grant or when Dixon leaves the board, unless he elected a later payment date under the Deferred Compensation Plan.

Is this Elevance Health (ELV) Form 4 transaction an open-market stock purchase?

No, this transaction is not an open-market purchase. The Form 4 reports a grant of deferred stock units as director compensation, with a transaction price per share of zero, rather than a buy or sell on the stock market.

Under what program were the Elevance Health (ELV) deferred stock units granted?

The deferred stock units were granted under the Elevance Health, Inc. Board of Directors Compensation Program. The award is also administered through the company’s Board of Directors Deferred Compensation Plan, which governs the timing and form of eventual share settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dixon Robert L JR

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	10,885	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)